Paper39354529
Traditional Chinese medicine for the treatment of cancers of hepatobiliary system: from clinical evidence to drug discovery.
Wu J and 8 others. Mol Cancer, 2024. Cited by 50 papers, by iCite.
Cite this record
ConductScience Library. Traditional Chinese medicine for the treatment of cancers of hepatobiliary system: from clinical evidence to drug discovery. Papers, record 39354529. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39354529
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Traditional Chinese medicine for the treatment of cancers of hepatobiliary system: from clinical evidence to drug discovery.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Medicine, Chinese Traditional | Major topic |
| Drugs, Chinese Herbal | Major topic |
| Drug Discovery | Major topic |
| Liver Neoplasms | Major topic |
| Humans | |
| Biliary Tract Neoplasms | |
| Animals |
Source PubMed
References264
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37928255 | Genipin-activating PPARγ impedes CCR2-mediated macrophage infiltration into postoperative liver to suppress recurrence of hepatocellular carcinoma. | Int J Biol Sci | 2023 | https://conductscience.org/library/papers/37928255 | PubMed |
| 2 | 22326673 | Old formula, new Rx: the journey of PHY906 as cancer adjuvant therapy. | J Ethnopharmacol | 2012 | https://conductscience.org/library/papers/22326673 | PubMed |
| 3 | 32242383 | Comparative efficacy and safety of Chinese herbal injections combined with transcatheter hepatic arterial chemoembolization in treatment of liver cancer: a bayesian network Meta-analysis. | J Tradit Chin Med | 2020 | https://conductscience.org/library/papers/32242383 | PubMed |
| 4 | 37806155 | Ginsenoside Rh2 and its octyl ester derivative inhibited invasion and metastasis of hepatocellular carcinoma via the c-Jun/COX2/PGE2 pathway. | Phytomedicine | 2023 | https://conductscience.org/library/papers/37806155 | PubMed |
| 5 | 31377293 | A polysaccharide from Huaier ameliorates cisplatin nephrotoxicity by decreasing oxidative stress and apoptosis via PI3K/AKT signaling. | Int J Biol Macromol | 2019 | https://conductscience.org/library/papers/31377293 | PubMed |
| 6 | 35397286 | Effect of kangai injection combined with platinum-based chemotherapy on the immune function of patients with advanced non-small-cell lung cancer: A meta-analysis. | Phytomedicine | 2022 | https://conductscience.org/library/papers/35397286 | PubMed |
| 7 | 35534947 | Ginsenoside Rh2 mitigates doxorubicin-induced cardiotoxicity by inhibiting apoptotic and inflammatory damage and weakening pathological remodelling in breast cancer-bearing mice. | Cell Prolif | 2022 | https://conductscience.org/library/papers/35534947 | PubMed |
| 8 | 33354776 | Icaritin inhibits PD-L1 expression by Targeting Protein IκB Kinase α. | Eur J Immunol | 2021 | https://conductscience.org/library/papers/33354776 | PubMed |
| 9 | 36909174 | Wogonin induces ferroptosis in pancreatic cancer cells by inhibiting the Nrf2/GPX4 axis. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/36909174 | PubMed |
| 10 | 33984593 | Fuzheng Jiedu Xiaoji formulation inhibits hepatocellular carcinoma progression in patients by targeting the AKT/CyclinD1/p21/p27 pathway. | Phytomedicine | 2021 | https://conductscience.org/library/papers/33984593 | PubMed |
| 11 | 25207889 | Kanglaite injection combined with hepatic arterial intervention for unresectable hepatocellular carcinoma: a meta-analysis. | J Cancer Res Ther | 2014 | https://conductscience.org/library/papers/25207889 | PubMed |
| 12 | 33990545 | Therapeutic potential of targeting membrane-spanning proteoglycan SDC4 in hepatocellular carcinoma. | Cell Death Dis | 2021 | https://conductscience.org/library/papers/33990545 | PubMed |
| 13 | 31427001 | HP-1 inhibits the progression of ccRCC and enhances sunitinib therapeutic effects by suppressing EMT. | Carbohydr Polym | 2019 | https://conductscience.org/library/papers/31427001 | PubMed |
| 14 | 34838619 | A novel strategy to reveal clinical advantages and molecular mechanism of aidi injection in the treatment of pancreatic cancer based on network meta-analysis and network pharmacology. | J Ethnopharmacol | 2022 | https://conductscience.org/library/papers/34838619 | PubMed |
| 15 | 29673791 | The effects of polysaccharides from Auricularia auricula (Huaier) in adjuvant anti-gastrointestinal cancer therapy: A systematic review and network meta-analysis. | Pharmacol Res | 2018 | https://conductscience.org/library/papers/29673791 | PubMed |
| 16 | 38378644 | HMGB1 promotes mitochondrial transfer between hepatocellular carcinoma cells through RHOT1 and RAC1 under hypoxia. | Cell Death Dis | 2024 | https://conductscience.org/library/papers/38378644 | PubMed |
| 17 | 22607709 | Down-regulation of the PI3K/Akt signaling pathway and induction of apoptosis in CA46 Burkitt lymphoma cells by baicalin. | J Exp Clin Cancer Res | 2012 | https://conductscience.org/library/papers/22607709 | PubMed |
| 18 | 31872855 | Efficacy and safety of Chinese patent medicine (Jinlong capsule) in the treatment of advanced hepatocellular carcinoma: a meta-analysis. | Biosci Rep | 2020 | https://conductscience.org/library/papers/31872855 | PubMed |
| 19 | 38561768 | Cancer-derived exosomes as novel biomarkers in metastatic gastrointestinal cancer. | Mol Cancer | 2024 | https://conductscience.org/library/papers/38561768 | PubMed |
| 20 | 39242496 | Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma. | Mol Cancer | 2024 | https://conductscience.org/library/papers/39242496 | PubMed |
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42891387 | Knowledge Mapping and Frontier Evolution of Traditional Medicine in Hepatocellular Carcinoma Research: A Bibliometric Analysis. | J Hepatocell Carcinoma | 2026 | https://conductscience.org/library/papers/42891387 | PubMed |
| 42890064 | Survival outcomes of spleen-strengthening and dampness-eliminating traditional Chinese medicine granules combined with lenvatinib for unresectable hepatocellular carcinoma: a large-sample retrospective study based on electronic medical records. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42890064 | PubMed |
| 42878941 | Integrative therapy with Qinghao Biejia Decoction improves survival after resection of intrahepatic cholangiocarcinoma. | J Mol Histol | 2026 | https://conductscience.org/library/papers/42878941 | PubMed |
| 42857277 | Ginsenoside Rb1 From the Functional Food Panax ginseng Suppresses Pancreatic Cancer Progression via Macrophage Reprogramming Through the PI3K-AKT Pathway. | Food Sci Nutr | 2026 | https://conductscience.org/library/papers/42857277 | PubMed |
| 42794982 | Combining Selective Internal Radiation Therapy (SIRT) and Systemic Therapy in Intrahepatic Cholangiocarcinoma. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42794982 | PubMed |
| 42677101 | Cordycepin ameliorates ischemia/reperfusion-induced acute kidney injury via inhibiting apoptosis and necroptosis. | Iran J Basic Med Sci | 2026 | https://conductscience.org/library/papers/42677101 | PubMed |
| 42577953 | TCM-Driven Circadian Modulation in Cancer: Engineering Spatiotemporal Drug Delivery for Precision Oncology. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42577953 | PubMed |
| 42455421 | Targeting SLC7A11 with Chinese Medicine for Tumor Ferroptosis Induction: From Molecular Mechanisms to Novel Precision Therapeutic Strategies. | Chin J Integr Med | 2026 | https://conductscience.org/library/papers/42455421 | PubMed |
| 42298665 | Ethnomedicinal plants used by Guoshan Yao minority communities in the foothills of Nanling Mountain, Guangdong, China. | J Ethnobiol Ethnomed | 2026 | https://conductscience.org/library/papers/42298665 | PubMed |
| 42293741 | Lipid nanoparticles and extracellular vesicles: emerging cell free therapeutic platforms for hepatobiliary cancers. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42293741 | PubMed |
| 42266751 | Schisandrin A suppresses hepatocellular carcinoma and sensitizes to sorafenib via modulating retinol metabolism. | Am J Cancer Res | 2026 | https://conductscience.org/library/papers/42266751 | PubMed |
| 42192454 | Research advances in the application of betulinic acid for anti-inflammatory and anti-tumour therapy. | Chin Med | 2026 | https://conductscience.org/library/papers/42192454 | PubMed |
| 42163812 | Self-Assembly of Stimuli-Responsive Peptide Enhances Therapeutics by Specifically Disrupting Hepatocellular Carcinoma Lysosomes In Vivo. | Adv Mater | 2026 | https://conductscience.org/library/papers/42163812 | PubMed |
| 42141267 | Integrating Network Pharmacology and Experimental Validation to Elucidate the Role of Huaier in Attenuating Liver Fibrosis via the AKT Signalling Pathway. | Clin Exp Med | 2026 | https://conductscience.org/library/papers/42141267 | PubMed |
| 42042068 | Natural Products in Endometrial Cancer: Molecular Mechanisms, Preclinical Evidence, and Clinical Perspectives. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/42042068 | PubMed |
| 41993589 | Bioactive plant and fungal metabolites in oral cancer: molecular mechanisms and translational potential. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/41993589 | PubMed |
| 41929489 | Dual role of icaritin in attenuating allograft rejection and exerting antitumor effects in mice. | Front Immunol | 2026 | https://conductscience.org/library/papers/41929489 | PubMed |
| 41909727 | Targeting MEK2 by paeoniflorin: Mechanism underlying its protection against hypobaric hypoxia-induced lung injury. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/41909727 | PubMed |
| 41668791 | Machine learning-driven optimization of extraction process and development of quality standards for traditional Chinese medicine (TCM) formulae in primary liver cancer. | RSC Adv | 2026 | https://conductscience.org/library/papers/41668791 | PubMed |
| 41629743 | Gut microbial ammonia as a mediator of PFOS neurotoxicity and its remediation by the flavonoid Icaritin. | Gut Microbes | 2026 | https://conductscience.org/library/papers/41629743 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39354529
GET https://conductscience.org/api/papers/v1/39354529/references?page=2